Drug Profile
FE 999008
Latest Information Update: 21 Nov 2006
Price :
$50
*
At a glance
- Originator Ferring Pharmaceuticals
- Class Gastric antisecretories
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gastric damage
Most Recent Events
- 29 Oct 2003 Phase-I clinical trials in Gastric damage in United Kingdom (unspecified route)